Back to the full story11 sources · Moderna and Merck’s mRNA Melanoma Vaccine Looks Like a Game Changer◆ Timeline
Moderna and Merck’s mRNA Melanoma Vaccine Looks Like a Game Changer
13 reports in the order each was filed. Tap any entry to open that report at its source.
- 01Ars TechnicaAug 19, 4:53 PMMRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
- 02AxiosAug 19, 8:04 PMModerna and Merck shares soar on mRNA cancer vaccine
- 03CNBCAug 19, 8:34 PMCancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar
- 04Scientific AmericanAug 19, 8:45 PMModerna and Merck announce ‘landmark’ trial showing mRNA therapy significantly cuts odds of recurrent skin cancer
- 05CBS NewsAug 19, 11:31 PMExperimental melanoma vaccine shows promising results
- 06CBS NewsAug 19, 11:33 PMModerna stock surges as melanoma vaccine trial shows "landmark moment
- 07NatureAug 20, 12:00 AMModerna cancer vaccine stops melanoma returning: what’s next for personalized treatments?
- 08CBS NewsAug 20, 1:03 AMHow Moderna's melanoma mRNA vaccine could fight deadliest skin cancer
- 09NPRAug 20, 8:45 AMNew mRNA vaccine could reduce the recurrence and spread of skin cancer
- 10STATAug 20, 10:30 AMSTAT+: One of the most consequential years for cancer treatment, ever
- 11CBS News — TopAug 20, 2:02 PMThis mRNA vaccine could potentially prevent the return of the deadliest form of skin cancer
- 12PBS NewsHourAug 20, 2:49 PMModerna shares surge after it says experimental mRNA cancer treatment passed key test
- 13GizmodoAug 20, 4:15 PMModerna and Merck’s mRNA Melanoma Vaccine Looks Like a Game Changer